Indiva Net debt/EBITDA
What is the Net debt/EBITDA of Indiva?
The Net debt/EBITDA of Indiva Ltd. is -13.08
What is the definition of Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA of companies in the Health Care sector on TSXV compared to Indiva
What does Indiva do?
Indiva Limited operates as a licensed producer of cannabis products in Canada. It creates premium pre-rolls, flower, capsules, and edible products, as well as provides production and manufacturing services to peer entities. The company produces and distributes the Bhang Chocolate, Wana Sour Gummies, Ruby Cannabis Sugar, Sapphire Cannabis Salt, Artisan Batch, and other powered by INDIVA products through license agreements and partnerships. Indiva Limited is based in Ottawa, Canada.
Companies with net debt/ebitda similar to Indiva
- ECO Animal Health plc has Net debt/EBITDA of -13.13
- Global Sweeteners has Net debt/EBITDA of -13.12
- Taylor Devices has Net debt/EBITDA of -13.09
- OSE Immunotherapeutics SA has Net debt/EBITDA of -13.09
- Kamada Ltd has Net debt/EBITDA of -13.09
- AM has Net debt/EBITDA of -13.09
- Indiva has Net debt/EBITDA of -13.08
- Echelon has Net debt/EBITDA of -13.07
- Inseego has Net debt/EBITDA of -13.05
- Cipher Pharmaceuticals has Net debt/EBITDA of -13.05
- IXICO plc has Net debt/EBITDA of -13.03
- Altair Engineering Inc has Net debt/EBITDA of -13.00
- Avio S.p.A has Net debt/EBITDA of -13.00